CD4-directed Blocking Antibody class drugs
1 result
Trogarzo (ibalizumab)
(ibalizumab)Theratechnologies Inc.
Usage: TROGARZO is indicated for treating HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1, specifically for those failing their current antiretroviral regimen when used in combination with other antiretroviral therapies.